CureDM, Inc. is actively expanding its portfolio of development stage products through in-licensing, acquisition and co-development partnering. We are focusing on pipeline products and technology candidates that may prove effective in the treatment of diabetes and other diseases of metabolism.

In addition to in-licensing, CureDM is actively seeking to partner with pharmaceutical companies with an established market presence to most effectively commercialize our products.

If you are interested in discussing partnering or licensing opportunities with CureDM, Inc., please contact us directly at at 610.645.6796 or through our web contact form.